1. Home
  2. LSCC vs ASND Comparison

LSCC vs ASND Comparison

Compare LSCC & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lattice Semiconductor Corporation

LSCC

Lattice Semiconductor Corporation

N/A

Current Price

$129.19

Market Cap

17.2B

Sector

Technology

ML Signal

N/A

Logo Ascendis Pharma A/S

ASND

Ascendis Pharma A/S

HOLD

Current Price

$253.95

Market Cap

15.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LSCC
ASND
Founded
1983
2006
Country
United States
Denmark
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
17.2B
15.2B
IPO Year
1994
2014

Fundamental Metrics

Financial Performance
Metric
LSCC
ASND
Price
$129.19
$253.95
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
12
16
Target Price
$103.75
$281.50
AVG Volume (30 Days)
1.8M
626.3K
Earning Date
05-04-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.16
N/A
Revenue
$385,961,000.00
N/A
Revenue This Year
$36.12
$96.35
Revenue Next Year
$19.98
$44.91
P/E Ratio
$863.31
N/A
Revenue Growth
N/A
N/A
52 Week Low
$46.48
$161.09
52 Week High
$157.01
$282.15

Technical Indicators

Market Signals
Indicator
LSCC
ASND
Relative Strength Index (RSI) 44.40 49.74
Support Level $128.23 $213.28
Resistance Level $155.94 $282.15
Average True Range (ATR) 6.55 7.76
MACD -0.14 -3.04
Stochastic Oscillator 47.72 12.90

Price Performance

Historical Comparison
LSCC
ASND

About LSCC Lattice Semiconductor Corporation

Lattice Semiconductor Corp is a developer of semiconductor technology that it distributes through products, solutions, and licenses. The company reaches its customers through consumer, communications, and industrial markets. The company has one operating segment namely the core Lattice business that includes silicon-based and silicon-enabling products, evaluation boards, development hardware, and related intellectual property licensing, services, and sales. The products of the company are offered globally; and, the majority of sales are derived from customers in Asia. It also has its presence in Americas and Europe.

About ASND Ascendis Pharma A/S

Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.

Share on Social Networks: